Medipharm Labs Corp
TSX:LABS
Medipharm Labs Corp
Depreciation & Amortization
Medipharm Labs Corp
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Depreciation & Amortization
CA$1.9m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Depreciation & Amortization
$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Depreciation & Amortization
CA$41.8m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
48%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Depreciation & Amortization
CA$56.1m
|
CAGR 3-Years
45%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Depreciation & Amortization
$13.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
65%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Depreciation & Amortization
CA$51.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
22%
|
CAGR 10-Years
87%
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Depreciation & Amortization?
Depreciation & Amortization
1.9m
CAD
Based on the financial report for Jun 30, 2025, Medipharm Labs Corp's Depreciation & Amortization amounts to 1.9m CAD.
What is Medipharm Labs Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-12%
Over the last year, the Depreciation & Amortization growth was -33%. The average annual Depreciation & Amortization growth rates for Medipharm Labs Corp have been -27% over the past three years , -12% over the past five years .
You don't have any saved screeners yet